Head and Neck Cancer: Clinical Usefulness and Accuracy of PET/CT Image Fusion

Radiology

Volumn 231, Issue 1, 2004, Pages 65-72

  Schöder, Heiko ^a   Yeung, Henry W D ^a   Gonen, Mithat ^a   Kraus, Dennis ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Computed tomography (CT); Dual modality imaging, PET CT; Head and neck neoplasms; Images, fusion; Positron emission tomography (PET)

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EVALUATION; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; PARAMETER; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PATIENT CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642275593     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2311030271     Document Type: Article

References (26)

1. Curtin H, Ishwararn H, Mancuso H, Dalley B, Caudry D, McNeil B. Comparison of CT and MRI imaging in staging of neck metastases. Radiology 1998; 207:123-130.
2. Greven KM, Williams DW 3rd, Keyes JW Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74:1355-1359.
3. Ojiri H, Mendenhall WM, Mancuso AA. CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys 2002; 52:748-754.
4. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998; 16:3550-3555.
5. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200: 135-141.
6. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34:12-17.
7. Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002; 24:127-135.
8. Adams S, Baum R, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25:1255-1260.
9. Stokkel MP, ten Broek FW, Hordijk GJ, Koole R, van Rijk PP. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg 2000; 231:229-234.
10. Hannah A, Scott AM, Tochon-Danguy H, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002; 236:208-217.
11. Lowe VJ, Dunphy FR, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997; 19:666-674.
12. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000; 36:858-867.
13. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002; 20:4199-4208.
14. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000; 18:651-658.
15. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001; 23: 933-941.
16. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379.
17. Yeung H, Schoder H, Larson S. Utility of PET/CT for assessing equivocal PET lesions in oncology: initial experience (abstr). J Nucl Med 2002; 43:32P.
18. Martinelli M, Townsend D, Meltzer C, Villemagne VV. 7. Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility. Clin Positron Imaging 2000; 3:161.
19. Eliasziw M, Donner A. Application of the McNemar test to non-independent matched pair data. Stat Med 1991; 10:1981-1991.
20. Gonen M, Panageas K, Larson S. Statistical issues in the analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001; 221:763-767.
21. Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002; 20:1398-1404.
22. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET: a possible prognostic factor in head and neck cancer. Br J Cancer 2002; 86:512-516.
23. Nakamoto Y, Cohade C, Osman M, Marshall L, Fishman E, Wahl R. Normal FDG distribution in head and neck region: PET/CT evaluation (abstr). Radiology 2002; 225(P):333.
24. 18F-FDG PET/CT. J Nucl Med 2003; 44:170-176.
25. Lardinois D, Weder W, Harry TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507.
26. Keberle M, Tschammler A, Berning K, Hahn D. Spiral CT of the neck: when do neck malignancies delineate best during contrast enhancement? Eur Radiol 2001; 11:1986-1990.